Prognostic Value of Elevated Cardiac Troponin I Levels in Pre-dialysis Chronic Kidney Disease Patients without Cardiac Symptoms

Evaluation of novel biomarkers for early diagnosis of bisphenol A-induced coronary artery disease

“…Traditionally, monitoring, treatment, or prevention strategies of patients with CVD have assessed cardiac troponin I, myoglobin, and CK-MB [ [23] , [24] , [25] , [26] , [27] ]. These biomarkers are usually elevated in the end stage of cardiac muscle degeneration stage, representing the “point of no return” for the patient [ 28 ].…”